These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

452 related items for PubMed ID: 25501703

  • 21. Circulating miR-148/152 family as potential biomarkers in hepatocellular carcinoma.
    Wang F, Ying H, He B, Pan Y, Sun H, Wang S.
    Tumour Biol; 2016 Apr; 37(4):4945-53. PubMed ID: 26531720
    [Abstract] [Full Text] [Related]

  • 22. Serum miR-223: A Validated Biomarker for Detection of Early-Stage Non-Small Cell Lung Cancer.
    D'Antona P, Cattoni M, Dominioni L, Poli A, Moretti F, Cinquetti R, Gini E, Daffrè E, Noonan DM, Imperatori A, Rotolo N, Campomenosi P.
    Cancer Epidemiol Biomarkers Prev; 2019 Nov; 28(11):1926-1933. PubMed ID: 31488416
    [Abstract] [Full Text] [Related]

  • 23. Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer.
    Liu Q, Yu Z, Yuan S, Xie W, Li C, Hu Z, Xiang Y, Wu N, Wu L, Bai L, Li Y.
    Oncotarget; 2017 Feb 21; 8(8):13048-13058. PubMed ID: 28055956
    [Abstract] [Full Text] [Related]

  • 24. Low plasma miR-25 expression is a favorite prognosis factor in non-small cell lung cancer.
    Zhang YL, Zhang ZL, Zhu XB, Xu L, Lu P, Xu M, Liu WJ, Zhang XY, Yao HM, Ye XW.
    Eur Rev Med Pharmacol Sci; 2019 Jun 21; 23(12):5251-5259. PubMed ID: 31298376
    [Abstract] [Full Text] [Related]

  • 25. MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer.
    Li W, Wang Y, Zhang Q, Tang L, Liu X, Dai Y, Xiao L, Huang S, Chen L, Guo Z, Lu J, Yuan K.
    PLoS One; 2015 Jun 21; 10(8):e0134220. PubMed ID: 26237047
    [Abstract] [Full Text] [Related]

  • 26. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Tian L, Shan W, Zhang Y, Lv X, Li X, Wei C.
    Pathol Oncol Res; 2016 Jan 21; 22(1):161-7. PubMed ID: 26453197
    [Abstract] [Full Text] [Related]

  • 27. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
    Kumar S, Sharawat SK, Ali A, Gaur V, Malik PS, Kumar S, Mohan A, Guleria R.
    Curr Probl Cancer; 2020 Aug 21; 44(4):100540. PubMed ID: 32007320
    [Abstract] [Full Text] [Related]

  • 28. A unique set of 6 circulating microRNAs for early detection of non-small cell lung cancer.
    Halvorsen AR, Bjaanæs M, LeBlanc M, Holm AM, Bolstad N, Rubio L, Peñalver JC, Cervera J, Mojarrieta JC, López-Guerrero JA, Brustugun OT, Helland Å.
    Oncotarget; 2016 Jun 14; 7(24):37250-37259. PubMed ID: 27191990
    [Abstract] [Full Text] [Related]

  • 29. Serum level of microRNA-147 as diagnostic biomarker in human non-small cell lung cancer.
    Chu G, Zhang J, Chen X.
    J Drug Target; 2016 Aug 14; 24(7):613-7. PubMed ID: 26581116
    [Abstract] [Full Text] [Related]

  • 30. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer.
    Hetta HF, Zahran AM, El-Mahdy RI, Nabil EE, Esmaeel HM, Elkady OA, Elkady A, Mohareb DA, Mahmoud Mostafa M, John J.
    Asian Pac J Cancer Prev; 2019 Jun 01; 20(6):1927-1933. PubMed ID: 31244320
    [Abstract] [Full Text] [Related]

  • 31. Evaluating the diagnostic and prognostic value of serum miR-770 in non-small cell lung cancer.
    Sun B, Liu HF, Ding Y, Li Z.
    Eur Rev Med Pharmacol Sci; 2018 May 01; 22(10):3061-3066. PubMed ID: 29863251
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A novel circulating miRNA-based signature for the early diagnosis and prognosis prediction of non-small-cell lung cancer.
    Zhou C, Chen Z, Zhao L, Zhao W, Zhu Y, Liu J, Zhao X.
    J Clin Lab Anal; 2020 Nov 01; 34(11):e23505. PubMed ID: 33463758
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Serum microRNA biomarkers for detection of non-small cell lung cancer.
    Hennessey PT, Sanford T, Choudhary A, Mydlarz WW, Brown D, Adai AT, Ochs MF, Ahrendt SA, Mambo E, Califano JA.
    PLoS One; 2012 Nov 01; 7(2):e32307. PubMed ID: 22389695
    [Abstract] [Full Text] [Related]

  • 37. Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.
    Powrózek T, Krawczyk P, Kowalski DM, Winiarczyk K, Olszyna-Serementa M, Milanowski J.
    Transl Res; 2015 Oct 01; 166(4):315-23. PubMed ID: 26079400
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A Novel Serum 4-microRNA Signature for Lung Cancer Detection.
    Nadal E, Truini A, Nakata A, Lin J, Reddy RM, Chang AC, Ramnath N, Gotoh N, Beer DG, Chen G.
    Sci Rep; 2015 Jul 23; 5():12464. PubMed ID: 26202143
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.